Good to know that this concern already raised in 2014. assume necessary measures have been taken since then, so the primary endpoint was met in the latest trial, which they missed in the first two trails.
I was attending the Webcast, being honest, this lady from FDA didn't impress me with her questions, sounded very flat, and reading the questions from somewhere, maybe from the 2014 findings.
Good to know that this concern already raised in 2014. assume...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.14 |
Change
-0.035(2.98%) |
Mkt cap ! $1.295B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.19 | $1.12 | $7.413M | 6.491M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 23017 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.14 | 33195 | 15 |
View Market Depth
| Last trade - 13.02pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.13 |
Change
-0.035 ( 4.33 %) |
||||
| Open | High | Low | Volume | ||
| $1.17 | $1.17 | $1.12 | 829421 | ||
| Last updated 13.18pm 08/05/2024 ? | |||||
| MSB (ASX) Chart |